(SCR) SCOR SE - Ratings and Ratios
Life Reinsurance, Non-Life Reinsurance, Financial Solutions, Longevity
SCR EPS (Earnings per Share)
SCR Revenue
Description: SCR SCOR SE
SCOR SE is a leading global reinsurer operating in over 100 countries, providing a comprehensive range of life and non-life reinsurance products. The companys diversified business model is structured into two main segments: SCOR P&C and SCOR L&H, allowing it to capitalize on various market opportunities while mitigating risk. The SCOR P&C segment is a major player in the property and casualty reinsurance market, offering a broad spectrum of products that cater to diverse client needs, from property and motor insurance to specialty lines like cyber and environmental liability. Meanwhile, the SCOR L&H segment focuses on life reinsurance, providing protection against mortality, morbidity, and other behavioral risks, as well as financial solutions and longevity products that help clients manage their balance sheets and improve solvency.
The companys asset management business adds another layer of diversification to its revenue streams, leveraging its financial expertise to generate returns. With a history dating back to 1956, SCOR SE has established itself as a stalwart in the reinsurance industry, headquartered in Paris, France, and boasting a significant global presence. Its reinsurance products are designed to help clients manage risk, improve capital efficiency, and achieve their business objectives. The companys commitment to delivering innovative solutions and exceptional client service has earned it a reputation as a trusted partner in the industry.
Analyzing the
To achieve this target, SCOR SE will need to continue executing its business strategy effectively, leveraging its strengths in the reinsurance market, and capitalizing on emerging trends and opportunities. The companys ability to manage risk, innovate its product offerings, and maintain its financial stability will be crucial in driving its growth and delivering value to shareholders. As the reinsurance industry continues to evolve, SCOR SE is well-positioned to navigate the changing landscape and capitalize on new opportunities, making it an attractive investment prospect for those looking to tap into the industrys potential.
Additional Sources for SCR Stock
SCR Stock Overview
Market Cap in USD | 6,098m |
Sector | Financial Services |
Industry | Insurance - Reinsurance |
GiC Sub-Industry | Reinsurance |
IPO / Inception |
SCR Stock Ratings
Growth Rating | 49.5 |
Fundamental | -2.95 |
Dividend Rating | 53.7 |
Rel. Strength | -3.09 |
Analysts | - |
Fair Price Momentum | 28.18 EUR |
Fair Price DCF | 93.08 EUR |
SCR Dividends
Dividend Yield 12m | 7.21% |
Yield on Cost 5y | 10.11% |
Annual Growth 5y | 0.00% |
Payout Consistency | 73.9% |
Payout Ratio | 30.0% |
SCR Growth Ratios
Growth Correlation 3m | 70.4% |
Growth Correlation 12m | 88.5% |
Growth Correlation 5y | 51.6% |
CAGR 5y | 8.80% |
CAGR/Max DD 5y | 0.17 |
Sharpe Ratio 12m | 0.42 |
Alpha | 2.01 |
Beta | 0.971 |
Volatility | 31.42% |
Current Volume | 420.9k |
Average Volume 20d | 313.4k |
As of July 03, 2025, the stock is trading at EUR 27.38 with a total of 420,872 shares traded.
Over the past week, the price has changed by -1.51%, over one month by -5.39%, over three months by +9.23% and over the past year by +24.18%.
Neither. Based on ValueRay´s Fundamental Analyses, SCOR SE is currently (July 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -2.95 and therefor a neutral outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of SCR is around 28.18 EUR . This means that SCR is currently overvalued and has a potential downside of 2.92%.
SCOR SE has no consensus analysts rating.
According to our own proprietary Forecast Model, SCR SCOR SE will be worth about 31.4 in July 2026. The stock is currently trading at 27.38. This means that the stock has a potential upside of +14.54%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 30.6 | 11.8% |
Analysts Target Price | - | - |
ValueRay Target Price | 31.4 | 14.5% |